Back
Kazia Therapeutics Ltd. Stock Predictions
When an AI Platform Gets Pulled by Too Much Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
15
KZIA
Kazia Therapeutics Ltd.
Last Price:
$5.94
Seasonality Move:
2.65%
7 Day Trial
ALL ACCESS PASS
$
7
Size matters when it's your portfolio.
Invest now at $0.85/shareKazia Therapeutics Ltd. Stock Forecast
-
Over the next 52 weeks, Kazia Therapeutics Ltd. has on average historically fallen by 3.5% based on the past 27 years of stock performance.
-
Kazia Therapeutics Ltd. has fallen lower in 19 of those 27 years over the subsequent 52-week period, corresponding to a historical accuracy of 70.37%
-
Is Kazia Therapeutics Ltd. Stock Undervalued?The current Kazia Therapeutics Ltd. [KZIA] share price is $6.00. The Score for KZIA is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
-
KZIA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Kazia Therapeutics Ltd. Stock Go Up Next Year?
-
Over the next 52 weeks, Kazia Therapeutics Ltd. has on average historically fallen by 3.5% based on the past 27 years of stock performance.
Kazia Therapeutics Ltd. Stock Rating
Sell
15
Kazia Therapeutics Ltd. (KZIA)
is a Sell
Is Kazia Therapeutics Ltd. overpriced?
-
Kazia Therapeutics Ltd. has fallen lower in 19 of those 27 years over the subsequent 52-week period, corresponding to a historical accuracy of 70.37%
Kazia Therapeutics Ltd. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Australia
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
kaziatherapeutics.com
52-Week Data
52-Week High:
17.40
52-Week Low:
2.86
Prediction Charts
Market Cap:
68M
Price in USD:
6.00
Volume:
72.3K
Beta:
1.77
Technical Analysis
SMA50:
8.70
SMA100:
8.00
SMA200:
7.32
52-Wk Change:
-14.36%
Stock Predictions
-
Is Kazia Therapeutics Ltd. stock public?Yes, Kazia Therapeutics Ltd. is a publicly traded company.
-
What is the Kazia Therapeutics Ltd. stock quote today?The Kazia Therapeutics Ltd. stock price is 6.00 USD today.
-
How to buy Kazia Therapeutics Ltd. stock online?You can buy Kazia Therapeutics Ltd. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-15 | 6.97 | 7.01 | 7.25 | 6.51 |
| Jan-16 | 7.02 | 7.16 | 7.41 | 6.90 |
| Jan-20 | 7.08 | 7.04 | 7.32 | 6.85 |
| Jan-21 | 7.00 | 7.08 | 7.69 | 7.00 |
| Jan-22 | 7.14 | 7.00 | 7.50 | 7.00 |
| Jan-23 | 7.02 | 7.51 | 7.52 | 6.98 |
| Jan-26 | 7.52 | 7.93 | 8.18 | 7.33 |
| Jan-27 | 7.80 | 7.15 | 7.80 | 6.00 |
| Jan-28 | 7.16 | 6.56 | 7.46 | 6.50 |
| Jan-29 | 6.52 | 6.10 | 6.64 | 5.96 |
| Jan-30 | 6.18 | 5.86 | 6.35 | 5.28 |
| Feb-2 | 5.70 | 6.20 | 6.31 | 5.60 |
| Feb-3 | 6.14 | 6.06 | 6.53 | 5.90 |
| Feb-4 | 6.01 | 6.00 | 6.25 | 5.80 |
Kazia Therapeutics Ltd. Earnings
Kazia Therapeutics Ltd. Earnings Report: Per Share Kazia Therapeutics Ltd. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Kazia Therapeutics Ltd. Forecast Revenue Growth
Kazia Therapeutics Ltd. Stock Analysis: Historical quarterly revenues per share for Kazia Therapeutics Ltd. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and an increase next year of $0.00 per share.
* Kazia Therapeutics Ltd. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.